메뉴 건너뛰기




Volumn 128, Issue 1, 2011, Pages 42-46

Asymmetric dimethylarginine impairs fibrinolytic activity in human umbilical vein endothelial cells via p38 MAPK and NF-κB pathways

Author keywords

Asymmetric dimethylarginine (ADMA); Mitogen activated protein kinase (MAPK); Nuclear factor kappaB (NF B); plasminogen activator inhibitor 1 (PAI 1); Tissue plasminogen activator (tPA)

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ARGININE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; N(G),N(G) DIMETHYLARGININE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PYRROLIDINE DITHIOCARBAMATE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79958051800     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.02.013     Document Type: Article
Times cited : (7)

References (27)
  • 1
    • 0344306684 scopus 로고    scopus 로고
    • Association of asymmetric dimethylarginine and endothelial dysfunction
    • DOI 10.1515/CCLM.2003.225
    • Böger RH. Association of asymmetric dimethylarginine and endothelial dysfunction. Clin Chem Lab Med 2003;41(11):1467-72. (Pubitemid 37493562)
    • (2003) Clinical Chemistry and Laboratory Medicine , vol.41 , Issue.11 , pp. 1467-1472
    • Boger, R.H.1
  • 2
    • 4744339386 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor
    • Böger RH. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor. J Nutr 2004;134:2842S-7S.
    • (2004) J Nutr , vol.134
    • Böger, R.H.1
  • 3
    • 0026548912 scopus 로고
    • Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
    • Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992;339:572-5.
    • (1992) Lancet , vol.339 , pp. 572-575
    • Vallance, P.1    Leone, A.2    Calver, A.3    Collier, J.4    Moncada, S.5
  • 5
    • 54249118627 scopus 로고    scopus 로고
    • Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia
    • Vladimirova-Kitova L, Deneva T, Angelova E, Nikolov F, Marinov B, Mateva N. Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia. Clin Physiol Funct Imaging 2008;28(6):417-25.
    • (2008) Clin Physiol Funct Imaging , vol.28 , Issue.6 , pp. 417-425
    • Vladimirova-Kitova, L.1    Deneva, T.2    Angelova, E.3    Nikolov, F.4    Marinov, B.5    Mateva, N.6
  • 6
    • 0034975920 scopus 로고    scopus 로고
    • Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine
    • DOI 10.1016/S0735-1097(01)01318-3, PII S0735109701013183
    • Lundman P, Eriksson MJ, Stühlinger M, Cooke JP, Hamsten A, Tornvall P. Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol 2001;38:111-6. (Pubitemid 32613836)
    • (2001) Journal of the American College of Cardiology , vol.38 , Issue.1 , pp. 111-116
    • Lundman, P.1    Eriksson, M.J.2    Stuhlinger, M.3    Cooke, J.P.4    Hamsten, A.5    Tornvall, P.6
  • 7
    • 0037010008 scopus 로고    scopus 로고
    • Plasma asymmetric dimethylarginine and hyperaemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia
    • Päivä H, Laakso J, Laine H, Laaksonen R, Knuuti J, Raitakari OT. Plasma asymmetric dimethylarginine and hyperaemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia. J Am Coll Cardiol 2002;40:1241-7.
    • (2002) J Am Coll Cardiol , vol.40 , pp. 1241-1247
    • Päivä, H.1    Laakso, J.2    Laine, H.3    Laaksonen, R.4    Knuuti, J.5    Raitakari, O.T.6
  • 8
    • 61949358942 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension
    • Wang D, Strandgaard S, Iversen J, Wilcox CS. Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am J Physiol Regul Integr Comp Physiol 2009;296(2):R195-200.
    • (2009) Am J Physiol Regul Integr Comp Physiol , vol.296 , Issue.2
    • Wang, D.1    Strandgaard, S.2    Iversen, J.3    Wilcox, C.S.4
  • 9
    • 65249119330 scopus 로고    scopus 로고
    • Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community
    • Böger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, et al. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 2009;119(12):1592-600.
    • (2009) Circulation , vol.119 , Issue.12 , pp. 1592-1600
    • Böger, R.H.1    Sullivan, L.M.2    Schwedhelm, E.3    Wang, T.J.4    Maas, R.5    Benjamin, E.J.6
  • 10
    • 66349098445 scopus 로고    scopus 로고
    • Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography
    • Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, PinskyDJ, et al. Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography. Coron Artery Dis 2009;20(2):112-7.
    • (2009) Coron Artery Dis , vol.20 , Issue.2 , pp. 112-117
    • Cavusoglu, E.1    Ruwende, C.2    Chopra, V.3    Yanamadala, S.4    Eng, C.5    Pinsky, D.J.6
  • 11
    • 77950975714 scopus 로고    scopus 로고
    • A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease
    • Ding H, Wu B, Wang H, Lu Z, Yan J, Wang X, et al. A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease. Circ Res 2010;106(6):1145-52.
    • (2010) Circ Res , vol.106 , Issue.6 , pp. 1145-1152
    • Ding, H.1    Wu, B.2    Wang, H.3    Lu, Z.4    Yan, J.5    Wang, X.6
  • 12
    • 35549008481 scopus 로고    scopus 로고
    • Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: Role in platelet hyperaggregability in hypertension
    • de Meirelles LR, Mendes-Ribeiro AC, Santoro MM, Mendes MA, da Silva MN, Mann GE, et al. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension. Clin Exp Pharmacol Physiol 2007;34(12):1267-71.
    • (2007) Clin Exp Pharmacol Physiol , vol.34 , Issue.12 , pp. 1267-1271
    • De Meirelles, L.R.1    Mendes-Ribeiro, A.C.2    Santoro, M.M.3    Mendes, M.A.4    Da Silva, M.N.5    Mann, G.E.6
  • 13
    • 67650915289 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine induces tissue factor expression in monocytes via NF-kappaB-dependent pathway: Role in acute coronary syndromes
    • Jiang DJ, Cao Y, Xin HY, Li XH, Luo ZQ, Li YJ. Asymmetric dimethylarginine induces tissue factor expression in monocytes via NF-kappaB-dependent pathway: Role in acute coronary syndromes. Atherosclerosis 2009;205(2):554-60.
    • (2009) Atherosclerosis , vol.205 , Issue.2 , pp. 554-560
    • Jiang, D.J.1    Cao, Y.2    Xin, H.Y.3    Li, X.H.4    Luo, Z.Q.5    Li, Y.J.6
  • 14
    • 12844278573 scopus 로고    scopus 로고
    • Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis
    • DOI 10.1182/blood-2004-08-3253
    • Lisman T, de Groor PG, Meijers JCM, Rosendaal FR. Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood 2005;105(3):1102-5. (Pubitemid 40170881)
    • (2005) Blood , vol.105 , Issue.3 , pp. 1102-1105
    • Lisman, T.1    De Groot, P.G.2    Meijers, J.C.M.3    Rosendaal, F.R.4
  • 15
    • 56349109855 scopus 로고    scopus 로고
    • The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treatedwith streptokinase
    • Nilsson JB, Boman K, Jansson JH, Nilsson T, Näslund U. The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treatedwith streptokinase. J Thromb Thrombolysis 2008;26(3):188-95.
    • (2008) J Thromb Thrombolysis , vol.26 , Issue.3 , pp. 188-195
    • Nilsson, J.B.1    Boman, K.2    Jansson, J.H.3    Nilsson, T.4    Näslund, U.5
  • 16
    • 34548478103 scopus 로고    scopus 로고
    • Endogenous risk factors for deep-vein thrombosis in patients with acute spinal cord injuries
    • DOI 10.1038/sj.sc.3102018, PII 3102018
    • Aito S, Abbate R, Marcucci R, Cominelli E. Endogenous risk factors for deep-vein thrombosis in patients with acute spinal cord injuries. Spinal Cord 2007;45(9):627-31. (Pubitemid 47373820)
    • (2007) Spinal Cord , vol.45 , Issue.9 , pp. 627-631
    • Aito, S.1    Abbate, R.2    Marcucci, R.3    Cominelli, E.4
  • 17
    • 0035936390 scopus 로고    scopus 로고
    • Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine
    • DOI 10.1016/S0140-6736(01)07184-7
    • Valkonen VP, Päivä H, Salonen JT, Lakka TA, Lehtimäki T, Laakso J, et al. Risk of acute coronary events and serumconcentration of asymmetrical dimethylarginine. Lancet 2001;358(9299):2127-8. (Pubitemid 34094905)
    • (2001) Lancet , vol.358 , Issue.9299 , pp. 2127-2128
    • Valkonen, V.-P.1    Paiva, H.2    Salonen, J.T.3    Lakka, T.A.4    Lehtimaki, T.5    Laakso, J.6    Laaksonen, R.7
  • 18
    • 36448974517 scopus 로고    scopus 로고
    • Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
    • Itakura H, Sobel BE, Boothroyd D, Leung LL, Iribarren C, Go AS, et al. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina? Am Heart J 2007;154(6):1059-64.
    • (2007) Am Heart J , vol.154 , Issue.6 , pp. 1059-1064
    • Itakura, H.1    Sobel, B.E.2    Boothroyd, D.3    Leung, L.L.4    Iribarren, C.5    Go, A.S.6
  • 19
    • 21344439852 scopus 로고    scopus 로고
    • Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction
    • DOI 10.1111/j.1365-2796.2005.01507.x
    • Lundblad D, Dinesen B, Rautio A, Røder ME, Eliasson M. Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction. J Intern Med 2005;258(1):13-20. (Pubitemid 40904928)
    • (2005) Journal of Internal Medicine , vol.258 , Issue.1 , pp. 13-20
    • Lundblad, D.1    Dinesen, B.2    Rautio, A.3    Roder, M.E.4    Eliasson, M.5
  • 21
    • 33644988090 scopus 로고    scopus 로고
    • Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition
    • DOI 10.1161/01.HYP.0000202478.79587.1a, PII 0000426820060300000030
    • Brown NJ, Muldowney 3rd JA, Vaughan DE. Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition. Hypertension 2006;47(3):441-8. (Pubitemid 43740288)
    • (2006) Hypertension , vol.47 , Issue.3 , pp. 441-448
    • Brown, N.J.1    Muldowney III, J.A.S.2    Vaughan, D.E.3
  • 22
    • 33644980666 scopus 로고    scopus 로고
    • Molecular mechanisms for the release of chemokines from human leukemicmast cell line (HMC)-1 cells activated by SCF and TNF-alpha: Roles of ERK, p38 MAPK, and NF-kappaB
    • Wong CK, Tsang CM, Ip WK, Lam CW. Molecular mechanisms for the release of chemokines from human leukemicmast cell line (HMC)-1 cells activated by SCF and TNF-alpha: roles of ERK, p38 MAPK, and NF-kappaB. Allergy 2006;61(3):289-97.
    • (2006) Allergy , vol.61 , Issue.3 , pp. 289-297
    • Wong, C.K.1    Tsang, C.M.2    Ip, W.K.3    Lam, C.W.4
  • 24
    • 77952430963 scopus 로고    scopus 로고
    • Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography
    • Cavusoglu E, Ruwende C, Chopra V, Poludasu S, Yanamadala S, Frishman WH, et al. Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography. Atherosclerosis 2010;210(1):226-31.
    • (2010) Atherosclerosis , vol.210 , Issue.1 , pp. 226-231
    • Cavusoglu, E.1    Ruwende, C.2    Chopra, V.3    Poludasu, S.4    Yanamadala, S.5    Frishman, W.H.6
  • 25
    • 69249211311 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease
    • Young JM, Terrin N, Wang X, Greene T, Beck GJ, Kusek JW, et al. Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease. Clin J Am Soc Nephrol 2009;4(6):1115-20.
    • (2009) Clin J Am Soc Nephrol , vol.4 , Issue.6 , pp. 1115-1120
    • Young, J.M.1    Terrin, N.2    Wang, X.3    Greene, T.4    Beck, G.J.5    Kusek, J.W.6
  • 26
    • 65949123566 scopus 로고    scopus 로고
    • Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: Implications for endothelial function in human atherosclerosis
    • Antoniades C, Shirodaria C, Leeson P, Antonopoulos A, Warrick N, Van-Assche T, et al. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur Heart J 2009;30(9):1142-50.
    • (2009) Eur Heart J , vol.30 , Issue.9 , pp. 1142-1150
    • Antoniades, C.1    Shirodaria, C.2    Leeson, P.3    Antonopoulos, A.4    Warrick, N.5    Van-Assche, T.6
  • 27
    • 77952067397 scopus 로고    scopus 로고
    • Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine
    • Jacobi J, Maas R, Cardounel AJ, Arend M, Pope AJ, Cordasic N, et al. Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine. Am J Pathol 2010;176(5):2559-70.
    • (2010) Am J Pathol , vol.176 , Issue.5 , pp. 2559-2570
    • Jacobi, J.1    Maas, R.2    Cardounel, A.J.3    Arend, M.4    Pope, A.J.5    Cordasic, N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.